For example, the analysis of mutations related to breast cancer risk would include BRCA1, BRCA2, PALB2, TP53, CHEK2, ATM, NBS/NBN, BLM, PTEN, MRE11, BRIP1, BARD1, RAD50, RAD51C, RAD51D, RECQL, FANCC, FANCM and perhaps some other genes (Sokolenko et al., 2012; Thompson et al., 2012; Kiiski et al., 2014; Kurian et al., 2014; Cybulski et al., 2015; Easton et al., 2015). This evidence concerns the gene BRCA2 and breast carcinoma.